IOT Insider Trading
Insider Ownership Percentage: 42.93%
Insider Buying (Last 12 Months): C$4,620.00
Insider Selling (Last 12 Months): C$14,417.50
Innovotech Share Price & Price History
Current Price: C$0.14
Price Change: +0.30 (1.20%)
As of 03/17/2025 04:55 PM ET
Innovotech Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
2/13/2025 | James Gregory Timourian | Senior Officer | Sell | 7,000 | C$0.22 | C$1,505.00 | | |
2/7/2025 | Bradley Alan Clark | Director | Buy | 16,000 | C$0.20 | C$3,120.00 | | |
2/7/2025 | James Gregory Timourian | Senior Officer | Sell | 10,000 | C$0.20 | C$1,950.00 | | |
12/4/2024 | James Gregory Timourian | Senior Officer | Sell | 30,000 | C$0.18 | C$5,250.00 | | |
11/25/2024 | James Gregory Timourian | Senior Officer | Sell | 2,500 | C$0.19 | C$462.50 | | |
11/20/2024 | James Gregory Timourian | Senior Officer | Sell | 30,000 | C$0.18 | C$5,250.00 | | |
6/24/2024 | Craig Milne | Director | Buy | 5,000 | C$0.10 | C$500.00 | | |
6/17/2024 | Craig Milne | Director | Buy | 10,000 | C$0.10 | C$1,000.00 | | |
2/21/2024 | Craig Milne | Director | Buy | 3,000 | C$0.75 | C$2,250.00 | | |
12/5/2023 | Craig Milne | Director | Buy | 50,000 | C$0.09 | C$4,500.00 | | |
12/5/2022 | James Gregory Timourian | Senior Officer | Buy | 1,500 | C$0.17 | C$255.00 | 1,928,088 | |
11/29/2022 | James Gregory Timourian | Senior Officer | Buy | 5,668 | C$0.19 | C$1,076.92 | 1,926,588 | |
10/25/2022 | Alan Clyde Hayes Savage | Insider | Buy | 25,000 | C$0.16 | C$4,000.00 | 60,000 | |
SEC Filings (Institutional Ownership Changes) for Innovotech (CVE:IOT)
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.
Read More on Innovotech
Today's Range
Now: C$0.14
52 Week Range
Now: C$0.14
Volume
2,500 shs
Average Volume
12,388 shs
Market Capitalization
C$5.46 million
P/E Ratio
N/A
Dividend Yield
10.00%
Beta
1.15
Who are the company insiders with the largest holdings of Innovotech?